Biotech by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Scholar Rock Holding leads the 24 biotech ranked by short interest, at 19.2%, ahead of CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Scholar Rock Holding19.2%
Median
9.33%
Combined market value
SAR 3.14T
Countries
5

Market values as of .

Biotech by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Scholar Rock HoldingSRRK · Health Care19.2%SAR 21.5BSAR 176.05 4.11% up 14% up United States
2CRISPR TherapeuticsCRSP · Health Care17.7%SAR 14.9BSAR 153.90 2.19% up 21% down Switzerland
3Twist BioscienceTWST · Health Care14.4%SAR 29BSAR 424.76 1.11% up 340% up United States
4Kodiak SciencesKOD · Health Care12.4%SAR 23.8BSAR 363.21 0.03% up 396% up United States
5Halozyme TherapeuticsHALO · Health Care12.0%SAR 41.2BSAR 361.56 0.44% up 37% up United States
6ImmunityBioIBRX · Health Care11.9%SAR 26.5BSAR 24.91 6.07% up 193% up United States
7RepligenRGEN · Health Care11.0%SAR 40.7BSAR 636.94 4.70% up 5% up United States
8ExelixisEXEL · Health Care10.5%SAR 62.7BSAR 256.76 0.07% down 63% up United States
9CG OncologyCGON · Health Care10.3%SAR 26.7BSAR 298.99 0.98% up 85% up United States
10Krystal BiotechKRYS · Health Care10.3%SAR 33.8BSAR 1,139.85 1.79% up 46% up United States
11Kymera TherapeuticsKYMR · Health Care9.84%SAR 38.9BSAR 455.54 0.06% down 87% up United States
12VaxcytePCVX · Health Care9.70%SAR 34.3BSAR 216.40 2.88% down 22% up United States
13ImmunovantIMVT · Health Care8.96%SAR 26BSAR 125.83 1.01% up 43% up United States
14ModernaMRNA · Health Care8.20%SAR 306.1BSAR 756.63 2.46% down 755% up United States
15Adaptive BiotechnologiesADPT · Health Care7.09%SAR 17.3BSAR 106.68 0.18% down 88% up United States
16Revolution MedicinesRVMD · Health Care6.05%SAR 128.8BSAR 595.55 2.41% down 131% up United States
17Neurocrine BiosciencesNBIX · Health Care5.83%SAR 61.4BSAR 606.44 2.56% down 20% up United States
18Bio-TechneTECH · Health Care4.90%SAR 42.8BSAR 272.74 0.11% up 26% up United States
19BiogenBIIB · Health Care3.69%SAR 137.8BSAR 932.16 0.91% down 49% up United States
20QiagenQGEN · Health Care3.10%SAR 38.4BSAR 185.84 0.41% down 12% up Netherlands
21AmgenAMGN · Health Care2.33%SAR 906.1BSAR 1,675.08 2.48% down 34% up United States
22argenxARGX · Health Care2.25%SAR 224.1BSAR 3,562.83 0.24% up 4% up Belgium
23Gilead SciencesGILD · Health Care1.72%SAR 782.8BSAR 631.14 1.17% down 33% up United States
24BioNTechBNTX · Health Care0.91%SAR 78BSAR 314.54 1.18% down 16% down Germany

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).

Questions and answers

Which biotech rank first by short interest?

Scholar Rock Holding (19.2%), CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%) are the top three of the 24 biotech ranked by short interest as of the 30 Oct 2026 settlement date.

How many biotech are in this ranking?

24 are ranked by short interest.

What are these biotech worth together?

The 24 biotech ranked by short interest have a combined market value of SAR 3.14T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.